A Phase 2, Double-blind, Randomized, Placebo-controlled Study to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol (GWP42003-P)
Phase of Trial: Phase II
Latest Information Update: 29 Jun 2017
At a glance
- Drugs Cannabidiol (Primary) ; Clobazam
- Indications Epilepsy
- Focus Pharmacokinetics
- Sponsors GW Pharmaceuticals
- 17 Mar 2017 Status changed from active, no longer recruiting to completed.
- 14 Jul 2016 Status changed from recruiting to active, no longer recruiting.
- 28 Jan 2016 Planned end date changed from 1 May 2016 to 1 Jun 2016, as reported by ClinicalTrials.gov.